Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
FY12 Budget Resolution and FY13 Appropriations: diabetes-related issues and issues related to modernizing cost estimates with respect to preventive health legislation and National Diabetes Prevention Program HR 2608 (PL 112-36) Continuing Appropriations Act, 2012; HJ RES 94 (PL 112-67); CR through 12/17/11; HJ RES 95 (PL 112-68) CR through 12/23/11; P.L. 112-74 Consolidated Appropriations Act of 2012 on National Diabetes Prevention Program
Preventing Diabetes in Medicare Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NOVO NORDISK INC. via NOVO NORDISK INC.
2012 · third_quarter · Q3
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
Source: Senate LDA
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction)
Preventing Diabetes in Medicare Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 112-25, Budget Control Act of 2011 (deficit reduction); HR 3743 Middle Class Tax Relief and Job Creation Act of 2011, HR 3630 Middle Class Tax Relief and Job Creation Act of 2011, and HR 3765 (PL 112-78) Temporary Payroll Tax Cut Continuation of 2011-Issues related to Medicaid rebates and similar revenue provisions; Medicaid coverage of obesity counseling and expanding provider type.
Preventing Diabetes in Medicare Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 6548 Medicare Diabetes Prevention Act of 2012; S 3463 Medicare Diabetes Prevention Act of 2012; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction)
Health Equity and Accountability Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults; PCORI Draft Research Agenda
Health Equity and Accountability Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, Special Diabetes Program reauthorization, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care in the Essential Health Benefits Package, IOM Committee on Valuing Community-Based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults; PCORI Draft Research Agenda
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, Special Diabetes Program reauthorization, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care in the Essential Health Benefits Package, IOM Committee on Valuing Community-Based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults; PCORI Draft Research Agenda
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults; PCORI Draft Research Agenda
Safeguarding America's Pharmaceuticals Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act (PDUFA V); H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
Safeguarding America's Pharmaceuticals Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
Temporary Payroll Tax Cut Continuation Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 112-25, Budget Control Act of 2011 (deficit reduction); HR 3743 Middle Class Tax Relief and Job Creation Act of 2011, HR 3630 Middle Class Tax Relief and Job Creation Act of 2011, and HR 3765 (PL 112-78) Temporary Payroll Tax Cut Continuation of 2011-Issues related to Medicaid rebates and similar revenue provisions; Medicaid coverage of obesity counseling and expanding provider type.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 112-25, Budget Control Act of 2011 (deficit reduction); HR 3743 Middle Class Tax Relief and Job Creation Act of 2011, HR 3630 Middle Class Tax Relief and Job Creation Act of 2011, and HR 3765 (PL 112-78) Temporary Payroll Tax Cut Continuation of 2011-Issues related to Medicaid rebates and similar revenue provisions; Medicaid coverage of obesity counseling and expanding provider type.
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
BPCA and PREA Reauthorization Act of 2012
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
BPCA and PREA Reauthorization Act of 2012
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act (PDUFA V); H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
H.R. 436 Protect Medical Innovation Act of 2011
H.R. 436 Protect Medical Innovation Act of 2011
H.R. 436 Protect Medical Innovation Act of 2011
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act (PDUFA V); H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
S. 3295 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2013 (National Diabetes Prevention Program); HR 6482 The Preventative Health Savings Act of 2012 (modernizing cost estimates with respect to CBO scoring of preventive health legislation); and National Diabetes Prevention Program
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 6548 Medicare Diabetes Prevention Act of 2012; S 3463 Medicare Diabetes Prevention Act of 2012; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction)
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
FY12 Budget Resolution: diabetes-related issues and issues related to modernizing cost estimates with respect to preventive health legislation; HR 2608 (PL 112-36) Continuing Appropriations Act, 2012; HJ RES 94 (PL 112-67); CR through 12/17/11; HJ RES 95 (PL 112-68) CR through 12/23/11; P.L. 112-74 Consolidated Appropriations Act of 2012 on National Diabetes Prevention Program
Preventing Diabetes in Medicare Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 112-25, Budget Control Act of 2011 (deficit reduction); HR 3743 Middle Class Tax Relief and Job Creation Act of 2011, HR 3630 Middle Class Tax Relief and Job Creation Act of 2011, and HR 3765 (PL 112-78) Temporary Payroll Tax Cut Continuation of 2011-Issues related to Medicaid rebates and similar revenue provisions
Health Equity and Accountability Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults
Health Equity and Accountability Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012
Temporary Payroll Tax Cut Continuation Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 112-25, Budget Control Act of 2011 (deficit reduction); HR 3743 Middle Class Tax Relief and Job Creation Act of 2011, HR 3630 Middle Class Tax Relief and Job Creation Act of 2011, and HR 3765 (PL 112-78) Temporary Payroll Tax Cut Continuation of 2011-Issues related to Medicaid rebates and similar revenue provisions
Temporary Payroll Tax Cut Continuation Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 112-25, Budget Control Act of 2011 (deficit reduction); HR 3743 Middle Class Tax Relief and Job Creation Act of 2011, HR 3630 Middle Class Tax Relief and Job Creation Act of 2011, and HR 3765 (PL 112-78) Temporary Payroll Tax Cut Continuation of 2011-Issues related to Medicaid rebates and similar revenue provisions
H.R. 436 Protect Medical Innovation Act of 2011
H.R. 436 Protect Medical Innovation Act of 2011
H.R. 436 Protect Medical Innovation Act of 2011
S. 1002 SAFE DOSES Act (Modernizing criminal laws concerning theft of medical products)
S. 1002 SAFE DOSES Act (Modernizing criminal laws concerning theft of medical products)
S. 1002 SAFE DOSES Act (Modernizing criminal laws concerning theft of medical products)
H.R. 436 Protect Medical Innovation Act of 2011
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, Special Diabetes Program reauthorization, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care in the Essential Health Benefits Package, IOM Committee on Valuing Community-Based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults; PCORI Draft Research Agenda
S. 3295 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2013 (National Diabetes Prevention Program); HR 6482 The Preventative Health Savings Act of 2012 (modernizing cost estimates with respect to CBO scoring of preventive health legislation); and National Diabetes Prevention Program
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 6548 Medicare Diabetes Prevention Act of 2012; S 3463 Medicare Diabetes Prevention Act of 2012; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction)
Trans-Pacific Partnership (TPP): biosimilar provisions
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, White House Office
NOVO NORDISK INC. via NOVO NORDISK INC.
2012 · second_quarter · Q2
S. 3295 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2013 (National Diabetes Prevention Program); Issues related to modernizing cost estimates with respect to preventive health legislation (scoring) and National Diabetes Prevention Program
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
Trans-Pacific Partnership (TPP): biosimilar provisions
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: biosimilar provisions
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction)
H.R. 436 Protect Medical Innovation Act of 2011
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act (PDUFA V); H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, White House Office
NOVO NORDISK INC. via NOVO NORDISK INC.
2012 · first_quarter · Q1
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults; PCORI Draft Research Agenda
FY12 Budget Resolution and FY13 Appropriations: diabetes-related issues and issues related to modernizing cost estimates with respect to preventive health legislation and National Diabetes Prevention Program HR 2608 (PL 112-36) Continuing Appropriations Act, 2012; HJ RES 94 (PL 112-67); CR through 12/17/11; HJ RES 95 (PL 112-68) CR through 12/23/11; P.L. 112-74 Consolidated Appropriations Act of 2012 on National Diabetes Prevention Program
H.R. 436 Protect Medical Innovation Act of 2011
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 112-25, Budget Control Act of 2011 (deficit reduction); HR 3743 Middle Class Tax Relief and Job Creation Act of 2011, HR 3630 Middle Class Tax Relief and Job Creation Act of 2011, and HR 3765 (PL 112-78) Temporary Payroll Tax Cut Continuation of 2011-Issues related to Medicaid rebates and similar revenue provisions; Medicaid coverage of obesity counseling and expanding provider type.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; HR 2112 FY12 Agriculture, Commerce/State/Justice, Transportation, & HUD Appropriations on prescription drug reimportation; Prescription Drug User Fee Act reauthorization Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; Supply Chain safety; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, White House Office
NOVO NORDISK INC. via NOVO NORDISK INC.
2011 · fourth_quarter · Q4
P.L. 112-29 (H.R. 1249 and S. 23), America Invents Act
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 112-25, Budget Control Act of 2011 (deficit reduction); HR 3743 Middle Class Tax Relief and Job Creation Act of 2011, HR 3630 Middle Class Tax Relief and Job Creation Act of 2011, and HR 3765 (PL 112-78) Temporary Payroll Tax Cut Continuation of 2011-Issues related to Medicaid rebates and similar revenue provisions
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; HR 2112 FY12 Agriculture, Commerce/State/Justice, Transportation, & HUD Appropriations on prescription drug reimportation; Prescription Drug User Fee Act reauthorization
FY12 Budget Resolution: diabetes-related issues and issues related to modernizing cost estimates with respect to preventive health legislation; HR 2608 (PL 112-36) Continuing Appropriations Act, 2012; HJ RES 94 (PL 112-67); CR through 12/17/11; HJ RES 95 (PL 112-68) CR through 12/23/11; P.L. 112-74 Consolidated Appropriations Act of 2012 on National Diabetes Prevention Program
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults
H.R. 436 Protect Medical Innovation Act of 2011
S. 1002 SAFE DOSES Act (Modernizing criminal laws concerning theft of medical products)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, White House Office
NOVO NORDISK INC. via NOVO NORDISK INC.
2011 · third_quarter · Q3
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; Deficit reduction and debt ceiling negotiations: Issues related to Medicare Parts B & D, Medicaid rebates and the 340B program, CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample transparency reporting provisions; prescription drug reimportation generally; Prescription Drug User Fee Act reauthorization
H.R. 1473 Department of Defense and Full Year Continuing Appropriations FY11; H.J. Res. 44, Further Continuing Appropriations FY11; H.J. Res. 48, Further Continuing Appropriations FY11; FY12 Budget Resolution: diabetes-related issues and issues related to modernizing cost estimates with respect to preventive health legislation
H.R. 436 Protect Medical Innovation Act of 2011
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012
H.R. 1249 and S. 23, America Invents Act
S. 1002 SAFE DOSES Act (Modernizing criminal laws concerning theft of medical products)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE
NOVO NORDISK INC. via NOVO NORDISK INC.
2011 · second_quarter · Q2
H.R. 1473 Department of Defense and Full Year Continuing Appropriations FY11; H.J. Res. 44, Further Continuing Appropriations FY11; H.J. Res. 48, Further Continuing Appropriations FY11; FY12 Budget Resolution: diabetes-related issues and issues related to modernizing cost estimates with respect to preventive health legislation
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, and Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package
H.R. 1249 and S. 23, America Invents Act
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample transparency reporting provisions; prescription drug reimportation generally; Prescription Drug User Fee Act reauthorization
H.R. 436 Protect Medical Innovation Act of 2011
S. 1002 SAFE DOSES Act (Modernizing criminal laws concerning theft of medical products)
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; Deficit reduction and debt ceiling negotiations: Issues related to Medicare Parts B & D, Medicaid rebates and the 340B program.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE